Literature DB >> 15024185

The expression of cytokine genes in the peritoneal macrophages and splenic CD4- and CD8-positive lymphocytes of the nonobese diabetic mice.

Nik-Soriani Yaacob1, Mohd-Arifin Kaderi, Mohd-Nor Norazmi.   

Abstract

Type 1 diabetes is an autoimmune disease that results from the destruction of the insulin-producing pancreatic beta islet cells, probably via the influence of cytokines. However, direct correlation between the expression of selected cytokines by various immune cells at different time points during the progression of the disease has not yet been clearly demonstrated. In this study, we showed that the mRNA expression of the pro-inflammatory cytokines, TNF-alpha, IL-1 beta, IL-6, and GM-CSF, were increased while the anti-inflammatory cytokine, TGF-beta, decreased in the peritoneal macrophages of nonobese diabetic (NOD) mice. IL-6 expression however decreased when the mice became diabetic. Surprisingly the expression of IFN-gamma and IL-2 by splenic CD4+ cells were lower in 5-week-old NOD mice as compared to the nonobese diabetic resistant (NOR) control mice, but their expression was higher in older NOD mice. The expression of IL-4 and IL-10 decreased in splenic CD4-positive lymphocytes. Splenic CD8-positive lymphocytes expressed increased levels of IFN-gamma and IL-10 but the latter decreased sharply when diabetes occurred. The relevance of these findings to the pathogenesis of type 1 diabetes is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024185     DOI: 10.1023/B:JOCI.0000019783.61674.1d

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  42 in total

Review 1.  Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells.

Authors:  J W Yoon; H S Jun; P Santamaria
Journal:  Autoimmunity       Date:  1998       Impact factor: 2.815

2.  Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism.

Authors:  W Suarez-Pinzon; G S Korbutt; R Power; J Hooton; R V Rajotte; A Rabinovitch
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

Review 3.  Tumor necrosis factor-alpha: a continuum of liability between insulin-dependent diabetes mellitus, non-insulin-dependent diabetes mellitus and carcinoma (review).

Authors:  R J Holden; I S Pakula; P A Mooney
Journal:  Med Hypotheses       Date:  1999-04       Impact factor: 1.538

Review 4.  Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.

Authors:  A Rabinovitch; W L Suarez-Pinzon
Journal:  Biochem Pharmacol       Date:  1998-04-15       Impact factor: 5.858

Review 5.  Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?

Authors:  A Rabinovitch
Journal:  Diabetes       Date:  1994-05       Impact factor: 9.461

6.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism.

Authors:  Iqbal S Grewal; Kate D Grewal; F Susan Wong; Hua Wang; Dominic E Picarella; Charles A Janeway; Richard A Flavell
Journal:  J Autoimmun       Date:  2002 Aug-Sep       Impact factor: 7.094

8.  Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus.

Authors:  M G von Herrath; M B Oldstone
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

9.  Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells.

Authors:  M Rincón; J Anguita; T Nakamura; E Fikrig; R A Flavell
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

10.  Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.

Authors:  M J Rapoport; A Jaramillo; D Zipris; A H Lazarus; D V Serreze; E H Leiter; P Cyopick; J S Danska; T L Delovitch
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  5 in total

1.  Nrf2 represses the onset of type 1 diabetes in non-obese diabetic mice.

Authors:  Yoko Yagishita; Akira Uruno; Dionysios V Chartoumpekis; Thomas W Kensler; Masayuki Yamamoto
Journal:  J Endocrinol       Date:  2019-01-01       Impact factor: 4.286

2.  Differential transcriptional expression of PPARalpha, PPARgamma1, and PPARgamma2 in the peritoneal macrophages and T-cell subsets of non-obese diabetic mice.

Authors:  Nik-Soriani Yaacob; Mohd Arifin Kaderi; Mohd-Nor Norazmi
Journal:  J Clin Immunol       Date:  2009-05-27       Impact factor: 8.317

3.  CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.

Authors:  Jeffrey D Price; Nicole M Beauchamp; Gwendoline Rahir; Yongge Zhao; Cosima C Rieger; Annie W Lau-Kilby; Kristin V Tarbell
Journal:  J Leukoc Biol       Date:  2013-09-30       Impact factor: 4.962

4.  Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy.

Authors:  Sebastien Bertin-Maghit; Dimeng Pang; Brendan O'Sullivan; Shannon Best; Emily Duggan; Sanjoy Paul; Helen Thomas; Thomas W H Kay; Leonard C Harrison; Raymond Steptoe; Ranjeny Thomas
Journal:  Diabetes       Date:  2010-10-27       Impact factor: 9.461

5.  The modulation of PPARγ1 and PPARγ2 mRNA expression by ciglitazone in CD3/CD28-activated naïve and memory CD4+ T cells.

Authors:  Mohd Nor Norazmi; Rafeezul Mohamed; Asma Abdullah Nurul; Nik Soriani Yaacob
Journal:  Clin Dev Immunol       Date:  2012-04-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.